Core Scientific Director Elizabeth Crain Buys 6,000 Shares
Key Points
The sale was valued at approximately $110,000.
This acquisition increased her direct equity holdings in the company by 9%.
The Core Scientific stock price has steadily outperformed the S&P 500 over the last year.
- 10 stocks we like better than Core Scientific ›
Elizabeth Crain, a Director at Core Scientific (NASDAQ:CORZ), executed a direct purchase of 6,000 shares of common stock on Aug. 20, 2026, according to a SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Transaction value | $109,980 |
| Shares purchased (directly held) | 6,000 |
| Post-transaction shares (directly held) | 71,348 |
| Post-transaction value | $1.3 million |
Transaction value based on SEC Form 4 weighted average purchase price ($18.33); post-transaction value based on Aug. 20, 2026, market close ($18.39).
Key questions
- What were the execution details of this purchase?
The shares were acquired in multiple transactions at prices ranging from $18.27 to $18.34, resulting in a weighted average execution price of $18.33 per share. - How does this transaction affect Crain's total ownership?
Following the purchase of 6,000 shares, Crain holds 71,348 shares directly, which represents her entire reported beneficial ownership stake in the company. - What is the current market context for Core Scientific?
Core Scientific is a North American enterprise engaged in digital asset mining and colocation services, with a market capitalization of $5.5 billion and a stock price of $17.81 as of the Aug. 21, 2026, market close. - What is the scale of the director's current equity position?
The total post-transaction holding of 71,348 shares corresponds to an insider ownership percentage of 0.02%.
Company Overview
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-21) | $17.81 |
| Market Capitalization | $5.5 billion |
| Revenue (TTM) | $440.3 million |
| Net Income (TTM) | -$1.6 billion |
Company Snapshot
- Core Scientific operates digital asset mining facilities and provides colocation services for blockchain infrastructure, generating revenue through proprietary cryptocurrency mining operations and hosting services for distributed ledger technology participants.
- The company's business model centers on leveraging owned and operated data centers equipped with specialized computing hardware to process blockchain transactions in exchange for digital asset rewards, while simultaneously monetizing excess capacity through colocation and hosting services to enterprise clients.
- Core Scientific serves enterprise customers and digital asset participants requiring high-performance computing infrastructure and colocation capabilities, targeting organizations seeking reliable, scalable blockchain and cryptocurrency mining operations.
Core Scientific is a North American leader in digital asset mining infrastructure, with a market capitalization of $5.5 billion and TTM revenue of $440.3 million. The company differentiates itself through vertically integrated data center operations and specialized expertise in blockchain infrastructure, positioning itself to capture value across both proprietary mining activities and third-party colocation services. With 325 employees and a geographically distributed footprint of owned facilities, Core Scientific maintains operational leverage in the evolving digital asset ecosystem.
What this transaction means for investors
There are plenty of reasons for an insider to sell shares. But the only reason someone buys shares is typically that they think the stock price will go up, which is a strong signal for shareholders. With the purchase of 6,000 shares, Crane has upped her stake to 71,348 shares. What's interesting about this purchase is that Crane picked up shares as the stock price rose rather than selling any shares to book profits, which, once again, is a sign of conviction in Core Scientific. Over the past 12 months, the stock price has been up 27.6%, compared with the S&P 500's 20% return over the same period.
Along with this insider purchase, another bullish signal for the stock is how analysts feel about it. According to CNN, of the 18 analysts who cover the Core Scientific, 94% rate it a buy, while only 6% rate it a hold. From that group, the median 12-month price target is $36, representing a massive 106.7% potential gain from today's price. The highest price target in that group is $55, representing a 215.9% profit, while even the lowest price target of $28 represents a 60.8% profit.
Should you buy stock in Core Scientific right now?
Before you buy stock in Core Scientific, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Core Scientific wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $446,157!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,377,357!*
Now, it’s worth noting Stock Advisor’s total average return is 984% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of September 3, 2026.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Recommended Articles
